A dangerous liaison between two major killers: Mycobacterium tuberculosis and HIV target dendritic cells through DC-SIGN

Journal of Experimental Medicine

Volumn 197, Issue 1, 2003, Pages 1-5

  Kaufmann, Stefan H E ^a   Schaible, Ulrich E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CELL SURFACE RECEPTOR; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 10; LECTIN; LIPOARABINOMANNAN; UNCLASSIFIED DRUG;

DENDRITIC CELL; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; INFECTION; INTRACELLULAR TRANSPORT; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NOTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CELL ADHESION MOLECULES; DENDRITIC CELLS; HIV; HUMANS; LECTINS, C-TYPE; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, CELL SURFACE; TUBERCULOSIS;

EID: 0037240321     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021964     Document Type: Note

References (30)

1. World Health Organisation. The World Health Report 2001. Geneva. 485 pp.
2. Kaufmann, S.H.E. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1:20-30.
3. Van Rie, A., R. Warren, M. Richardson, T.C. Victor, R.P. Gie, D.A. Enarson, N. Beyers, and P.D. van Helden. 1999. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 341:1174-1179.
4. Chinen, J., and W.T. Shearer. 2002. Molecular virology and immunology of HIV infection. J. Allergy Clin. Immunol. 110: 189-198.
5. Geijtenbeek, T.B., D.S. Kwon, R. Torensma, S.J. van Vliet, G.C. van Duijnhoven, J. Middel, I.L. Cornelissen, H.S. Nottet, V.N. Kewal Ramani, D.R. Littman, C.G. Figdor, and Y. van Kooyk. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell, 100:587-597.
6. Kwon, D.S., G. Gregorio, N. Bitton, W,A, Hendrickson, and D.R. Littman, 2002. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity. 16:135-144.
7. Sol-Foulon, N., A. Moris, C. Nobile, C. Boccaccio, A. Engering, J.P. Abastado, J.M. Heard, Y. van Kooyk, and O. Schwartz. 2002. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity. 16:145-155.
8. Geijtenbeek, T. S.J. van Vliet, E.A. Koppel, M, Sanchez-Hernandez, C.M.J.E. Vandenbroucke-Grauls, B. Appelmelk, and Y. van Kooyk. 2002. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197: 7-17.
9. Tailleux, L., O. Schwartz, J.L. Herrmann, E. Pivert, M. Jackson, A. Amara, L. Legres, D. Dreher, L.P. Nicod, J.C, Gluckman, et al. 2002. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197:119-125.
10. Geijtenbeek, T.B., R. Torensma, S.J, van Vliet, G.C. van Duijnhoven, G.J. Adema, Y. van Kooyk, and C.G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 100:575-585.
11. Engering, A., T. Geijtenbeek, and Y. van Kooyk. 2002. Immune escape through C-type lectins on dendritic cells. Trends Immunol. 23:480-485.
12. Geijtenbeek, T.B., G.C. van Duijnhoven, S.J. van Vliet, E. Krieger, G. Vriend, C.G. Figdor, and Y. van Kooyk. 2002. Identification of different binding sites in the dendritic cellspecific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1.J. Biol. Chem. 277:11314-11320.
13. Ehlers, M.R., and M. Daffe. 1998. Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key? Trends Microbiol. 6:328-335.
14. Schorey, J.S., M.C. Carroll, and E.J. Brown. 1997. A macrophage invasion mechanism of pathogenic mycobacteria. Science. 277:1091-1093.
15. Prigozy, T.I., P.A. Sieling, D. Clemens, P.L. Stewart, S.M. Behar, S.A. Porcelli, M.B. Brenner, R.L. Modlin, and M. Kronenberg. 1997. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity. 6:187-197.
16. Nigou, J., C. Zelle-Rieser, M. Gilleron, M. Thurnher, and G. Puzo. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166:7477-7485.
17. Jiao, X., R. Lo-Man, P. Guermonprez, L. Fiette, E. Deriaud, S. Burgaud, B. Gicquel, N. Winter, and C. Leclerc. 2002. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168:1294-1301.
18. Fortsch, D., M. Rollinghoff, and S. Stenger. 2000. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J. Immunol. 165:978-987.
19. Schaible, U.E., K. Hagens, K. Fischer, H.L. Collins, and S.H. Kaufmann. 2000. Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells. J. Immunol. 164:4843-4852.
20. Soilleux, E.J., L.S. Morris, G. Leslie, J. Chehimi, Q. Luo, E. Levroney, J. Trowsdale, L.J. Montaner, R.W. Doms, D. Weissman, et al. 2002. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71:445-457.
21. Engering, A., T.B. Geijtenbeek, S.J. van Vliet, M. Wijers, E. van Liempt, N. Demaurex, A. Lanzavecchia, J. Fransen, C.G. Figdor, V. Piguet, and Y. van Kooyk. 2002. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168:2118-2126.
22. Schaible, U.E., H.L. Collins, and S.H. Kaufmann. 1999. Confrontation between intracellular bacteria and the immune system. Adv. Immunol. 71:267-377.
23. Stenger, S., and R.L. Modlin. 1999. T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol. 2:89-93.
24. Heldwein, K.A., and M.J. Fenton. 2002. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 4:937-944.
25. Murray, P.J. 1999. Defining the requirements for immunological control of mycobacterial infections. Trends Microbial. 7:366-372.
26. Kaufmann, S.H.E. 2000. Is the development of a new tuberculosis vaccine possible? Nat. Med. 6:955-960.
27. Strohmeier, G.R., and M.J. Fenton. 1999. Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microbes Infect. 1:709-717.
28. Vanham, G., Z. Toossi, C.S. Hirsch, R.S. Wallis, S.K. Schwander, E.A. Rich, and J.J. Ellner. 1997. Examining a paradox in the pathogenesis of human pulmonary tuberculosis; immune activation and suppression/anergy. Tuber. Lung Dis. 78:145-158.
29. Fischer, K., D. Chatterjee, J. Torrelles, P.J. Brennan, S.H. Kaufmann, and U.E. Schaible. 2001. Mycobacterial lysocardiolipin is exported from phagosomes upon cleavage of cardiolipin by a macrophage-derived lysosomal phospholipase A2. J. Immunol. 167:2187-2192.
30. Beatty, W.L., E.R. Rhoades, H.J. Ullrich, D. Chatterjee, J.E. Heuser, and D.G. Russell. 2000. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic. 1:235-247.